[PR]今日のニュースは
「Infoseek モバイル」
-

Immunization of rats reduces nicotine distribution to
brain.
Hieda Y, Keyler DE, VanDeVoort JT, Niedbala RS, Raphael DE, Ross CA,
Pentel PR.
Minneapolis Medical Research Foundation, Minnesota, USA.
The effect of active immunization against nicotine on the initial
distribution of nicotine to brain was studied in anesthetized rats. Animals
received nicotine 0.03 mg/kg nicotine (equivalent to the nicotine dose
absorbed by a human smoking two cigarettes) as a rapid injection in the
jugular vein. In control animals, the arterial serum nicotine concentration
initially exceeded the venous concentration 4.6-fold, similar to the initial
arteriovenous difference produced by cigarette smoking in humans. Animals
immunized with the nicotine analog CMUNic maintained this arteriovenous
gradient, but with both arterial and venous nicotine concentrations several
times higher than in controls. The arterial nicotine concentration was
higher in immunized animals even at the first (7.5 s) sampling time. The
brain nicotine concentration at 3 min was 36% lower in the immunized
animals. The time course of nicotine distribution to brain was studied in a
second group of animals. Brain nicotine concentration was reduced in rats
immunized with CMUNic over the entire 6-min sampling period immediately
following nicotine dosing (mean reduction 38%). A reduction was found at the
earliest sampling time (30 s) and was maximal at 1 min (48%). Nicotine
protein binding in serum was markedly increased in animals immunized with
CMUNic compared to controls (91.2 versus 10.9%), and the unbound nicotine
concentration in serum was lower (10.0 versus 13.4 ng/ml). The reduction in
brain nicotine concentration correlated with antibody affinity for nicotine,
and the percentage of nicotine bound in serum. These data demonstrate that
nicotine-specific antibodies produced by active immunization rapidly bind
nicotine in arterial blood, reduce the unbound nicotine concentration, and
reduce the early distribution of nicotine to brain. Effects were observed
using a clinically relevant nicotine dose and route of administration. These
data suggest that the use of immunization to modify the behavioral effects
of nicotine may be possible.
PMID: 10326777 [PubMed - indexed for MEDLINE]
ホームページ | プロフィール | 研究報告リスト
筆者へのメールは kaijinhi@yahoo.co.jp
にお願いします。
このニコチンワクチンは臨床試験の研究段階です。
このページは商用目的ではありません。